(Q39292772)

10 September 2017

title

PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway (English)

1 reference

10 September 2017

Lanjun Xu

1

1 reference

10 September 2017

Jing Hu

2

1 reference

10 September 2017

Yuanbo Zhao

3

1 reference

10 September 2017

Jia Hu

4

1 reference

10 September 2017

Juan Xiao

5

1 reference

10 September 2017

Yanming Wang

6

1 reference

10 September 2017

Dalong Ma

7

1 reference

10 September 2017

Yingyu Chen

8

1 reference

10 September 2017

publication date

1 November 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

17

1 reference

10 September 2017

issue

11

1 reference

10 September 2017

page(s)

1235-1245

1 reference

https://scigraph.springernature.com/pub.10.1007/s10495-012-0754-x

10 September 2017

exact match

0 references

cites work

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Transcriptional regulation by p53: one protein, many possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

p53 has a direct apoptogenic role at the mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

The ubiquitin ligase COP1 is a critical negative regulator of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Post-translational modification of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Cell cycle checkpoint signaling through the ATM and ATR kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Enhanced phosphorylation of p53 by ATM in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

A role for ATR in the DNA damage-induced phosphorylation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Reduced expression of programmed cell death 5 protein in tissue of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5' regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Inhibition of HDM2 and activation of p53 by ribosomal protein L23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Regulation of HDM2 activity by the ribosomal protein L11

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Binding of p53-derived ligands to MDM2 induces a variety of long range conformational changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

Association of thePDCD5Locus With Lung Cancer Risk and Prognosis in Smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0754-X

10.1007/S10495-012-0754-X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference